Study to Assess the Effect of Treatment With Bendamustine in Combination With Rituximab on QT Interval in Patients With Advanced Indolent Non-Hodgkin's Lymphoma (NHL) or Mantle Cell Lymphoma (MCL)
Public ClinicalTrials.gov record NCT01073163. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Study to Assess the Effect of Treatment With Bendamustine in Combination With Rituximab on QT Interval in Patients With Advanced Indolent Non-Hodgkin's Lymphoma (NHL) or Mantle Cell Lymphoma (MCL)
Study identification
- NCT ID
- NCT01073163
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Cephalon
- Industry
- Enrollment
- 54 participants
Conditions and interventions
Conditions
Interventions
- Bendamustine Drug
- Rituximab Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2010
- Primary completion
- May 31, 2012
- Completion
- May 31, 2012
- Last update posted
- Apr 23, 2014
2010 – 2012
United States locations
- U.S. sites
- 36
- U.S. states
- 24
- U.S. cities
- 35
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Hematology Oncology Physicans Extenders Group | Tucson | Arizona | — | — |
| University of Arkansas for Medical Sciences | Little Rock | Arkansas | — | — |
| St. Jude Heritage Medical Group | Fullerton | California | — | — |
| Comprehensive Cancer Center | Palm Springs | California | — | — |
| University of Colorado Cancer Center | Aurora | Colorado | — | — |
| Rocky Mountain Cancer Center | Denver | Colorado | — | — |
| The Hospital of Central Connecticut | New Britain | Connecticut | — | — |
| Cancer Center of Central Connecticut | Southington | Connecticut | — | — |
| Memorial Cancer Institute | Hollywood | Florida | — | — |
| Cancer Centers of Florida | Orlando | Florida | — | — |
| MD Anderson Cancer Cnt Orlando | Orlando | Florida | — | — |
| John B Amos Cancer Center | Columbus | Georgia | — | — |
| St Francis Cancer Research Foundation | Beech Grove | Indiana | — | — |
| Cedar Valley Medical Specialists | Waterloo | Iowa | — | — |
| Cancer Center of Kansas | Wichita | Kansas | — | — |
| University of Kentucky | Lexington | Kentucky | — | — |
| LSU Health Sciences Center - Shreveport | Shreveport | Louisiana | — | — |
| MaineGeneral Medical Center | Augusta | Maine | — | — |
| Missouri Cancer Associates | Columbia | Missouri | — | — |
| Kansas City Cancer Center | Kansas City | Missouri | — | — |
| UNM Cancer Center/New Mexico Cancer Care Alliance | Albuquerque | New Mexico | — | — |
| Interlakes Foundation, Inc | Rochester | New York | — | — |
| SUNY Upstate / Upstate Medical University | Syracuse | New York | — | — |
| Willamette Valley Cancer Center | Springfield | Oregon | — | — |
| Geisinger Medical Center | Danville | Pennsylvania | — | — |
| Pennsylvania Oncology Hematology Associates, Inc. | Philadelphia | Pennsylvania | — | — |
| Charleston Hematology Oncology, PA | Charleston | South Carolina | — | — |
| Sarah Cannon Cancer Center | Nashville | Tennessee | — | — |
| Texas Oncology, P.A. | Fort Worth | Texas | — | — |
| Cancer Care Center of South Texas | San Antonio | Texas | — | — |
| Texas Oncology | Tyler | Texas | — | — |
| Virginia Oncology Associates | Norfolk | Virginia | — | — |
| Cancer Outreach Asscociates, PC | Richlands | Virginia | — | — |
| Cancer Care Northwest-South | Spokane | Washington | — | — |
| Northwest Cancer Specialists, PC | Vancouver | Washington | — | — |
| West Virginia University School of Medicine | Morgantown | West Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01073163, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 23, 2014 · Synced Jul 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01073163 live on ClinicalTrials.gov.